https://doi.org/10.1111/bjh.15661
P
Pam McKay
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
281
Papers
5.3K
Citations
31
h-index
65
i10-index
Pam McKay is an academic researcher from Semmelweis University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & CNS Lymphoma Diagnosis and Treatment. The author has an h-index of 31, co-authored 239 publications.
ORCID: 0000-0002-3959-9730Papers by this author
worksGuidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma
2018 · British Journal of Haematology · 160 citations
Guidelines for the investigation and management of mantle cell lymphoma
2012 · British Journal of Haematology · 78 citations
https://doi.org/10.1111/bjh.12046
Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline
2023 · British Journal of Haematology · 26 citations
https://doi.org/10.1111/bjh.19131
Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England
2021 · British Journal of Cancer · 23 citations
https://doi.org/10.1038/s41416-021-01525-4
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial
2024 · The Lancet Haematology · 9 citations
https://doi.org/10.1016/s2352-3026(24)00317-x
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study
2024 · The Lancet Oncology · 8 citations
https://doi.org/10.1016/s1470-2045(24)00598-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat